The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma
dc.contributor.author | Lewinska, Monika | |
dc.contributor.author | Santos-Laso, Alvaro | |
dc.contributor.author | Arretxe, Enara | |
dc.contributor.author | Alonso, Cristina | |
dc.contributor.author | Zhuravleva, Ekaterina | |
dc.contributor.author | Jimenez-Aguero, Raul | |
dc.contributor.author | Eizaguirre, Emma | |
dc.contributor.author | Jesus Pareja, Maria | |
dc.contributor.author | Romero-Gomez, Manuel | |
dc.contributor.author | Arrese, Marco | |
dc.contributor.author | Suppli, Malte P. | |
dc.contributor.author | Knop, Filip K. | |
dc.contributor.author | Oversoe, Stine Karlsen | |
dc.contributor.author | Villadsen, Gerda Elisabeth | |
dc.contributor.author | Decaens, Thomas | |
dc.contributor.author | Carrilho, Flair Jose | |
dc.contributor.author | de Oliveira, Claudia P. M. S. | |
dc.contributor.author | Sangro, Bruno | |
dc.contributor.author | Macias, Rocio I. R. | |
dc.contributor.author | Banales, Jesus M. | |
dc.contributor.author | Andersen, Jesper B. | |
dc.contributor.authoraffiliation | [Lewinska, Monika] Univ Copenhagen, Biotech Res & Innovat Ctr, Dept Hlth & Med Sci, Copenhagen, Denmark | |
dc.contributor.authoraffiliation | [Zhuravleva, Ekaterina] Univ Copenhagen, Biotech Res & Innovat Ctr, Dept Hlth & Med Sci, Copenhagen, Denmark | |
dc.contributor.authoraffiliation | [Andersen, Jesper B.] Univ Copenhagen, Biotech Res & Innovat Ctr, Dept Hlth & Med Sci, Copenhagen, Denmark | |
dc.contributor.authoraffiliation | [Santos-Laso, Alvaro] Univ Basque Country, UPV EHU, Donostia Univ Hosp, Dept Liver & Gastrointestinal Dis,Biodonostia Hlt, San Sebastian, Spain | |
dc.contributor.authoraffiliation | [Jimenez-Aguero, Raul] Univ Basque Country, UPV EHU, Donostia Univ Hosp, Dept Liver & Gastrointestinal Dis,Biodonostia Hlt, San Sebastian, Spain | |
dc.contributor.authoraffiliation | [Eizaguirre, Emma] Univ Basque Country, UPV EHU, Donostia Univ Hosp, Dept Liver & Gastrointestinal Dis,Biodonostia Hlt, San Sebastian, Spain | |
dc.contributor.authoraffiliation | [Banales, Jesus M.] Univ Basque Country, UPV EHU, Donostia Univ Hosp, Dept Liver & Gastrointestinal Dis,Biodonostia Hlt, San Sebastian, Spain | |
dc.contributor.authoraffiliation | [Arretxe, Enara] OWL Metabol, Derio, Spain | |
dc.contributor.authoraffiliation | [Alonso, Cristina] OWL Metabol, Derio, Spain | |
dc.contributor.authoraffiliation | [Jesus Pareja, Maria] Hosp Juan Ramon Jimenez Huelva, Huelva, Spain | |
dc.contributor.authoraffiliation | [Romero-Gomez, Manuel] Univ Seville, UCM Digest Dis, Virgen del Rocio Univ Hosp, SeLiver Grp,Inst Biomed Seville IBIS, Seville, Spain | |
dc.contributor.authoraffiliation | [Romero-Gomez, Manuel] Carlos III Natl Inst Hlth, Ctr Study Liver & Gastrointestinal Dis CIBERehd, Madrid, Spain | |
dc.contributor.authoraffiliation | [Sangro, Bruno] Carlos III Natl Inst Hlth, Ctr Study Liver & Gastrointestinal Dis CIBERehd, Madrid, Spain | |
dc.contributor.authoraffiliation | [Macias, Rocio I. R.] Carlos III Natl Inst Hlth, Ctr Study Liver & Gastrointestinal Dis CIBERehd, Madrid, Spain | |
dc.contributor.authoraffiliation | [Banales, Jesus M.] Carlos III Natl Inst Hlth, Ctr Study Liver & Gastrointestinal Dis CIBERehd, Madrid, Spain | |
dc.contributor.authoraffiliation | [Arrese, Marco] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Escuela Med, Dept Gastroenterol,Ctr Envejecimiento & Regenerat, Santiago, Chile | |
dc.contributor.authoraffiliation | [Suppli, Malte P.] Univ Copenhagen, Gentofte Hosp, Ctr Clin Metab Res, Hellerup, Denmark | |
dc.contributor.authoraffiliation | [Knop, Filip K.] Univ Copenhagen, Gentofte Hosp, Ctr Clin Metab Res, Hellerup, Denmark | |
dc.contributor.authoraffiliation | [Knop, Filip K.] Steno Diabet Ctr Copenhagen, Gentofte, Denmark | |
dc.contributor.authoraffiliation | [Oversoe, Stine Karlsen] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark | |
dc.contributor.authoraffiliation | [Villadsen, Gerda Elisabeth] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark | |
dc.contributor.authoraffiliation | [Decaens, Thomas] Univ Grenoble Alpes, Grenoble, France | |
dc.contributor.authoraffiliation | [Decaens, Thomas] CHU Grenoble Alpes, Dept Hepatol & Gastroenterol, Grenoble, France | |
dc.contributor.authoraffiliation | [Carrilho, Flair Jose] Univ Sao Paulo, Dept Gastroenterol, Fac Med, Sao Paulo, Brazil | |
dc.contributor.authoraffiliation | [de Oliveira, Claudia P. M. S.] Univ Sao Paulo, Dept Gastroenterol, Fac Med, Sao Paulo, Brazil | |
dc.contributor.authoraffiliation | [Sangro, Bruno] Clin Univ Navarra IDISNA, Liver Unit, Pamplona, Spain | |
dc.contributor.authoraffiliation | [Sangro, Bruno] CIBEREHD, Pamplona, Spain | |
dc.contributor.authoraffiliation | [Macias, Rocio I. R.] Univ Salamanca, IBSAL, Expt Hepatol & Drug Targeting HEVEPHARM Grp, Salamanca, Spain | |
dc.contributor.authoraffiliation | [Banales, Jesus M.] IKERBASQUE, Basque Fdn Sci, Bilbao, Spain | |
dc.contributor.funder | Novo Nordisk Foundation | |
dc.contributor.funder | Danish Cancer Society | |
dc.contributor.funder | Danish Medical Research Council | |
dc.contributor.funder | Spanish Ministry of Economy and Competitiveness | |
dc.contributor.funder | 'Instituto de Salud Carlos III' grants - 'Fondo Europeo de Desarrollo Regional' (FEDER) | |
dc.contributor.funder | CIBERehd, Spain | |
dc.contributor.funder | IKERBASQUE, Basque foundation for Science, Spain | |
dc.contributor.funder | BIOEF | |
dc.contributor.funder | Department of Health of the Basque Country | |
dc.contributor.funder | Euskadi RIS3 | |
dc.contributor.funder | Department of Industry of the Basque Country | |
dc.contributor.funder | AECC Scientific Foundation | |
dc.contributor.funder | European Commission Horizon 2020 program (ESCALON project) | |
dc.contributor.funder | Fondo Nacional De Ciencia y Tecnologia de Chile (FONDECYT) | |
dc.contributor.funder | Comision Nacional de Investigacion, Ciencia y Tecnologia (CONICYT) | |
dc.date.accessioned | 2025-01-07T14:36:31Z | |
dc.date.available | 2025-01-07T14:36:31Z | |
dc.date.issued | 2021-10-29 | |
dc.description.abstract | Background: Non-alcoholic fatty liver disease (NAFLD) is affecting more people globally. Indeed, NAFLD is a spectrum of metabolic dysfunctions that can progress to hepatocellular carcinoma (NAFLD-HCC). This development can occur in a non-cirrhotic liver and thus, often lack clinical surveillance. The aim of this study was to develop non-invasive surveillance method for NAFLD-HCC.Methods: Using comprehensive ultra-high-performance liquid chromatography mass-spectrometry, we investigated 1,295 metabolites in serum from 249 patients. Area under the receiver operating characteristic curve was calculated for all detected metabolites and used to establish their diagnostic potential. Logistic regression analysis was used to establish the diagnostic score.Findings: We show that NAFLD-HCC is characterised by a complete rearrangement of the serum lipidome, which distinguishes NAFLD-HCC from non-cancerous individuals and other HCC patients. We used machine learning to build a diagnostic model for NAFLD-HCC. We quantified predictive metabolites and developed the NAFLD-HCC Diagnostic Score (NHDS), presenting superior diagnostic potential compared to alpha-fetoprotein (AFP). Patients' metabolic landscapes show a progressive depletion in unsaturated fatty acids and acylcarnitines during transformation. Upregulation of fatty acid transporters in NAFLD-HCC tumours contribute to fatty acid depletion in the serum.Interpretation: NAFLD-HCC patients can be efficiently distinguished by serum metabolic alterations from the healthy population and from HCC patients related to other aetiologies (alcohol and viral hepatitis). Our model can be used for non-invasive surveillance of individuals with metabolic syndrome(s), allowing for early detection of NAFLD-HCC. Therefore, serum metabolomics may provide valuable insight to monitor patients at risk, including morbidly obese, diabetics, and NAFLD patients. (C) 2021 The Author(s). Published by Elsevier B.V. | |
dc.identifier.doi | 10.1016/j.ebiom.2021.103661 | |
dc.identifier.issn | 2352-3964 | |
dc.identifier.pmid | 34740106 | |
dc.identifier.unpaywallURL | http://www.thelancet.com/article/S2352396421004552/pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/26530 | |
dc.identifier.wosID | 721615900011 | |
dc.journal.title | Ebiomedicine | |
dc.journal.titleabbreviation | Ebiomedicine | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Juan Ramón Jiménez | |
dc.publisher | Elsevier | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | NAFLD | |
dc.subject | HCC | |
dc.subject | metabolomics | |
dc.subject | lipidomics | |
dc.subject | biomarker discovery | |
dc.subject | Disease | |
dc.subject | Obesity | |
dc.title | The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 73 | |
dc.wostype | Article |